scispace - formally typeset
Open AccessJournal ArticleDOI

Global cancer statistics

Reads0
Chats0
TLDR
A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Abstract
The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats

TL;DR: These mechanistic studies are the first to provide a rational biological explanation for the increased breast cancer risk in female night shift workers and show that the tumor growth response to exposure to light during darkness is intensity dependent and that the human nocturnal, circadian melatonin signal not only inhibits human breast cancer growth but that this effect is extinguished by short-term ocular exposure to bright, white light at night.
Journal ArticleDOI

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

TL;DR: Resistance to current chemotherapeutics available for the management of non-small cell lung cancer (NSCLC) represents one of the most significant barriers to improving long-term outcomes for this vulnerable patient group.
Journal ArticleDOI

Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.

TL;DR: The induction mechanisms and regulatory pathways of ferroptosis, a newly discovered type of cell death that differs from traditional apoptosis and necrosis and results from iron‐dependent lipid peroxide accumulation, are summarized and their roles in human tumourous diseases are clarified.
Journal ArticleDOI

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

TL;DR: T-lymphocytes infiltrating primary and metastatic ovarian cancer sites are associated with improved prognosis and are especially distinct in advanced stage patients, underlining the potential for immunotherapy as a broadly applicable therapeutic strategy.
Journal ArticleDOI

Gastric cancer epidemiology and risk factors.

TL;DR: The epidemiology of gastric cancer is discussed focusing on trends across various risk categories and individual diseases within a single organ—a distinction that will aid the understanding of disease heterogeneity and its significance.
References
More filters
Journal ArticleDOI

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book

Cancer Incidence in Five Continents

TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Book

International Classification of Diseases for Oncology

TL;DR: This list of diseases for oncology includes cancers of the central nervous system, as well as other types of diseases such as lymphoma, leukaemia, and so on.
Related Papers (5)
Trending Questions (2)
Global cancer statistics 2023?

The provided paper does not provide statistics for global cancer in 2023. The paper discusses global cancer burden, incidence, and mortality rates based on data from 2008.

What is factors that lead to cancer rate increasing nowadays?

The factors that lead to the increasing cancer rate nowadays include the aging and growth of the world population, adoption of cancer-causing behaviors (particularly smoking) in economically developing countries, and limited access to timely and standard treatment in developing countries.